These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25994561)

  • 21. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
    Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
    Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intensity modulated radiation therapy for 90 untreated nasopharyngeal carcinoma].
    Wei R; Jiang W; Su J; He L; Yang Z; Jiang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):173-8. PubMed ID: 22561435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
    Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
    Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center.
    Wu LR; Liu YT; Jiang N; Fan YX; Wen J; Huang SF; Guo WJ; Bian XH; Wang FJ; Li F; Song D; Wu JF; Jiang XS; Liu JY; He X
    Oral Oncol; 2017 Jun; 69():26-32. PubMed ID: 28559017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
    Lewis GD; Holliday EB; Kocak-Uzel E; Hernandez M; Garden AS; Rosenthal DI; Frank SJ
    Head Neck; 2016 Apr; 38 Suppl 1():E1886-95. PubMed ID: 26705956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
    Cao CN; Luo JW; Gao L; Yi JL; Huang XD; Wang K; Zhang SP; Qu Y; Li SY; Xiao JP; Zhang Z; Xu GZ
    PLoS One; 2015; 10(3):e0119101. PubMed ID: 25747589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity-modulated radiotherapy.
    Guo Q; Cui X; Lin S; Lin J; Pan J
    Head Neck; 2016 Apr; 38 Suppl 1():E665-72. PubMed ID: 25867086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
    Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma. Treatment results and locoregional recurrence.
    Chen JL; Huang YS; Kuo SH; Chen YF; Hong RL; Ko JY; Lou PJ; Tsai CL; Chen WY; Wang CW
    Strahlenther Onkol; 2013 Dec; 189(12):1001-8. PubMed ID: 24158634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
    Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
    Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Chua DT; Sham JS; Leung LH; Au GK
    Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
    Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.
    Wolden SL; Chen WC; Pfister DG; Kraus DH; Berry SL; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):57-62. PubMed ID: 15936155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
    Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
    Sanford NN; Lau J; Lam MB; Juliano AF; Adams JA; Goldberg SI; Lu HM; Lu YC; Liebsch NJ; Curtin HD; Chan AW
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):654-668. PubMed ID: 30712708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of reduced-volume, intensity-modulated radiation therapy on disease control in nasopharyngeal carcinoma.
    Lin YW; Chen CC; Lin LC; Lee SP
    PLoS One; 2015; 10(4):e0125283. PubMed ID: 25919285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT.
    Ng WT; Lee MC; Chang AT; Chan OS; Chan LL; Cheung FY; Hung WM; Chan CC; Lee AW
    Oral Oncol; 2014 May; 50(5):506-12. PubMed ID: 24529762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation therapy for nasopharyngeal carcinoma using simultaneously integrated boost (SIB) protocol: a comparison planning study between intensity modulated arc radiotherapy vs. intensity modulated radiotherapy.
    Liu T; Chen J; Gong G; Zhang G; Bai T; Sun T; Lu J; Ma C; Yin Y
    Technol Cancer Res Treat; 2012 Oct; 11(5):415-20. PubMed ID: 22568626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.